NCT01662609View on ClinicalTrials.gov

Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

August 23, 2007

Primary Completion Date

August 16, 2022

Study Completion Date

August 16, 2022

Conditions
Pancreatic Cancer
Interventions
PROCEDURE

Endoscopic Ultrasound (EUS)

Ultrasound scope will be passed through the participant's mouth into their stomach and their pancreas will be evaluated completely by the ultrasound scope. If an abnormality is found in their pancreas, a biopsy may be performed to obtain a diagnosis.

Trial Locations (2)

18105

Lehigh Valley Health Network, Allentown

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors
lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT01662609 - Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer | Biotech Hunter | Biotech Hunter